Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:NVDQ

(NVDQ) (NVDQ) Stock Price, News & Analysis

(NVDQ) logo

About (NVDQ) Stock (NASDAQ:NVDQ)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$3.50
$3.74
50-Day Range
N/A
52-Week Range
$5.84
$12.74
Volume
51.03 million shs
Average Volume
797,205 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
4.70%
Price Target
N/A
Consensus Rating
N/A

Company Overview

NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.

Remove Ads
Receive NVDQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NVDQ) and its competitors with MarketBeat's FREE daily newsletter.

NVDQ Stock News Headlines

Bitcoin's Climb Fuels Pre-Election Speculation
Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
NVDQ Oct 2024 3.000 call (NVDQ241018C00003000)
NVDQ Mar 2025 5.000 put (NVDQ250321P00005000)
See More Headlines

NVDQ Stock Analysis - Frequently Asked Questions

(NVDQ) (NASDAQ:NVDQ) released its earnings results on Wednesday, May, 3rd. The medical research company reported ($0.72) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.09. The medical research company earned $21.08 million during the quarter, compared to analysts' expectations of $20.12 million.

(NVDQ)'s stock reverse split on Tuesday, July 16th 2024. The 1-3 reverse split was announced on Tuesday, July 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Top institutional shareholders of (NVDQ) include Citadel Advisors LLC and Belvedere Trading LLC.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NVDQ) investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Athabasca Oil (ATH), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX) and Accenture (ACN).

Company Calendar

Last Earnings
5/03/2017
Today
3/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NVDQ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:NVDQ) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners